Takemura et al., 1999 - Google Patents
Heparin‐binding EGF‐like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritisTakemura et al., 1999
- Document ID
- 13273771685910726684
- Author
- Takemura T
- Murata Y
- Hino S
- Okada M
- Yanagida H
- Ikeda M
- Yoshioka K
- Publication year
- Publication venue
- The Journal of Pathology
External Links
Snippet
Heparin‐binding epidermal growth factor‐like growth factor (HB‐EGF), a new member of the EGF family, is mitogenic for several types of cells, through binding to cell surface heparan sulphate proteoglycans. This study has attempted to delineate HB‐EGF expression by …
- 210000003584 Mesangial Cells 0 title abstract description 60
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Takemura et al. | Heparin‐binding EGF‐like growth factor is expressed by mesangial cells and is involved in mesangial proliferation in glomerulonephritis | |
| He et al. | Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing | |
| RU2527182C2 (en) | Method for inducing stem cell migration in fatty tissue | |
| Barkho et al. | Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines | |
| Livant et al. | The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice | |
| Jacques et al. | Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity | |
| Wünsch et al. | In situ localization of transforming growth factor β1 in porcine heart: enhanced expression after chronic coronary artery constriction | |
| Schuger et al. | Retinoic acid stimulates mouse lung development by a mechanism involving epithelial-mesenchymal interaction and regulation of epidermal growth factor receptors | |
| JPH07504650A (en) | Inhibition of transforming growth factor β to prevent extracellular matrix accumulation | |
| Lee et al. | SDF-1α/CXCR4 signaling mediates digit tip regeneration promoted by BMP-2 | |
| Xiao et al. | IL‐10 gene‐modified human amniotic mesenchymal stem cells augment regenerative wound healing by multiple synergistic effects | |
| Rutti et al. | Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα | |
| KR102034496B1 (en) | Bioartificial proximal tubule systems and methods of use | |
| Logar et al. | Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo | |
| JP6583830B2 (en) | Cell sheet containing fibroblasts with peripheral blood mononuclear cells or factors secreted from peripheral blood mononuclear cells | |
| Faull et al. | HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration | |
| Liao et al. | Critical role of the endogenous renin-angiotensin system in maintaining self-renewal and regeneration potential of epidermal stem cells | |
| Gao et al. | Engineering neutrophil immunomodulatory hydrogels promoted angiogenesis | |
| Cai et al. | Apratyramide, a marine-derived peptidic stimulator of VEGF-A and other growth factors with potential application in wound healing | |
| Takeshita et al. | Thrombomodulin ameliorates transforming growth factor-β1–mediated chronic kidney disease via the G-protein coupled receptor 15/Akt signal pathway | |
| KR102294405B1 (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| Amiot et al. | The anti-fibrotic role of mast cells in the liver is mediated by HLA-G and interaction with hepatic stellate cells | |
| Nakanishi et al. | The expression and production of vascular endothelial growth factor in oral mucosa equivalents | |
| Bijelić et al. | Different functions of recombinantly expressed domains of tenascin-C in glial scar formation | |
| Wise et al. | Anti-fibrotic actions of equine interleukin-10 on transforming growth factor-beta1-stimulated dermal fibroblasts isolated from limbs of horses |